STOCK TITAN

Mountain Crest V holders approve CubeBio merger

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Mountain Crest Acquisition Corp. V (MCAG) shareholders approved the business combination agreement with CubeBio Co., Ltd. at the November 11, 2026 special meeting. All 2,419,694 shares represented at the meeting voted for the agreement. As of the September 14, 2026 record date, 2,873,023 shares were outstanding and entitled to vote; the shares represented at the meeting were approximately 84.22% of the outstanding shares.

Under the agreement, CHL SPAC Merger Sub would merge into Mountain Crest, which would survive as a direct wholly owned subsidiary of VIANIQ Holdings Limited, renamed from CubeBio Holdings Limited on October 20, 2026. Each Mountain Crest common share would convert into one PubCo ordinary share; CubeBio shareholders would transfer their shares for the right to receive PubCo ordinary shares. Shareholders also approved the proposed PubCo charter on a non-binding advisory basis, elected seven PubCo directors on a non-binding advisory basis, and approved PubCo’s equity incentive plan. In connection with the vote, 5,612 shares of publicly traded common stock were tendered for redemption.

Filing Explained

The proposed authorization describes capacity, not issuance: nine hundred ninety million ordinary shares and ten million preference shares.

The 8-K reports that shareholders approved the business combination agreement, but it does not report that the merger has closed; under the approved terms, each Mountain Crest common share would convert into one VIANIQ ordinary share at the merger.

Shareholders also approved the proposed VIANIQ charter on a non-binding advisory basis, which would replace 30,000,000 authorized Mountain Crest common shares with 990,000,000 VIANIQ ordinary shares and 10,000,000 preference shares.

Those are authorized amounts, not an issuance reported in this filing; issuing additional shares would increase the total share count and reduce existing holders’ percentage ownership absent offsetting changes.

Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Votes for business combination agreement 2,419,694 shares At the November 11, 2026 special meeting.
Common shares outstanding 2,873,023 shares As of the September 14, 2026 record date; entitled to vote at the special meeting.
Shares represented at meeting 2,419,694 shares Approximately 84.22% of outstanding shares.
Shares tendered for redemption 5,612 shares In connection with the November 11, 2026 shareholder vote.
Proposed PubCo ordinary shares authorized 990,000,000 shares Under the proposed PubCo charter approved on a non-binding advisory basis.
Proposed PubCo preference shares authorized 10,000,000 shares Under the proposed PubCo charter approved on a non-binding advisory basis.
Mountain Crest common shares authorized 30,000,000 shares Authorization under Mountain Crest’s existing charter, as described in comparison with the proposed PubCo charter.
Share conversion ratio 1 PubCo ordinary share per Mountain Crest common share Conversion term under the business combination agreement.
Business Combination Agreement technical
"approved the Business Combination Agreement and the Business Combination"
A business combination agreement is a detailed contract that lays out the terms for two companies to join together—covering price, how ownership will be split, the steps needed to close the deal, and what each side promises to do or avoid before closing. For investors it matters because the agreement determines potential changes in value, control, timing, and risk exposure—think of it like the playbook for a merger that shows who wins, who pays, and what could still derail the plan.
SPAC Merger technical
"SPAC Merger Sub will be merged with and into Mountain Crest"
A SPAC merger is when a private company combines with a SPAC, a publicly traded shell company created to find and buy a business, so the private company becomes publicly listed without a traditional initial public offering. Investors should care because this shortcut can speed up market access but often brings greater uncertainty about valuation, potential share dilution, and reliance on investor votes and future performance, which can increase stock volatility.
Share Swap technical
"the Share Swap and collectively with the SPAC Merger"
A share swap is an exchange where shareholders of one company receive shares in another company instead of cash, typically as part of a merger or acquisition. It matters to investors because it changes who owns what — like trading tickets to sit in a different section of the same stadium — which can affect the value of holdings, voting power, future dividends, and the risk profile of an investment.
quorum technical
"constituting a quorum for the Special Meeting"
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
broker non-votes technical
"broker non-votes had no effect on the outcome of the vote"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
ordinary resolution regulatory
"required the approval of an ordinary resolution"
An ordinary resolution is a decision made by shareholders at a company meeting that is approved when more than half of the votes cast are in favor. Think of it like a household vote where a majority decides routine matters — it covers everyday corporate actions such as approving directors, routine policy changes, or distributions, and matters to investors because these majority-approved choices shape governance, management authority, and the company’s near-term direction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Did MCAG shareholders approve the CubeBio business combination?

Yes. The proposal received 2,419,694 votes for, with 0 against, 0 abstentions and 0 broker non-votes. The represented shares were approximately 84.22% of the 2,873,023 shares outstanding and entitled to vote as of September 14, 2026.

How is the proposed MCAG-CubeBio business combination structured?

Under the approved agreement, CHL SPAC Merger Sub would merge into Mountain Crest, which would survive as a direct wholly owned subsidiary of VIANIQ Holdings Limited. Each Mountain Crest common share would convert into one PubCo ordinary share, while CubeBio shareholders would transfer their shares for the right to receive PubCo ordinary shares.

Who was elected to the PubCo board in the MCAG shareholder vote?

The seven PubCo director nominees elected were Jaemyung Kim, Hyejeoung Lee, Dr. Hoseong Han, Dr. Kyungha Yoo, Kyoomyong Yun, Dongseop Shin and Hong Kyu Jeon. Each received 2,419,694 votes for and zero votes withheld.

What shares does the proposed PubCo charter authorize?

Shareholders approved the proposal on a non-binding advisory basis. It proposes 990,000,000 PubCo ordinary shares and 10,000,000 PubCo preference shares, replacing the Mountain Crest charter’s authorization of 30,000,000 common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001859035 0001859035 2026-11-11 2026-11-11 0001859035 us-gaap:CommonStockMember 2026-11-11 2026-11-11 0001859035 us-gaap:RightsMember 2026-11-11 2026-11-11 0001859035 mcag:UnitsMember 2026-11-11 2026-11-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

November 11, 2026

Date of Report (Date of earliest event reported)

 

Mountain Crest Acquisition Corp. V

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-40418   86-1768041
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

524 Broadway 11th Floor
New York, NY
  10012
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (646)493-6558

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   MCAG    
Rights   MCAGR    
Units   MCAGU    

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

As previously disclosed, on August 29, 2024, Mountain Crest Acquisition Corp. V (the “Company”) entered into a business combination agreement, dated as of August 29, 2024, as modified by the Joinder Agreement (as defined below) (as amended, the “Business Combination Agreement”), with CubeBio Co., Ltd. (“CubeBio”), a corporation organized under the laws of the Republic of Korea, pursuant to which, subject to the approval and adoption of the Business Combination Agreement by the Stockholders, the following transactions will occur: (i) CHL SPAC Merger Sub, Inc., a Delaware corporation (“SPAC Merger Sub”) and a wholly owned subsidiary of PubCo (as defined below), will be merged with and into Mountain Crest with Mountain Crest being the surviving entity (the “SPAC Merger”), and following the SPAC Merger, a direct wholly owned subsidiary of CubeBio Holdings Limited, a Cayman Islands exempted company limited by shares (“PubCo”), and each share of common stock of Mountain Crest, par value $0.0001 per share (the “Mountain Crest Common Stock”), issued and outstanding prior to the SPAC Merger shall be converted into one PubCo ordinary shares, par value $0.0001 per share, and (ii) all shareholders of CubeBio shall transfer their respective common shares of CubeBio, par value $0.0001 per share to Cube Exchange Sub Co., Ltd., a corporation organized under the laws of the Republic of Korea, in exchange for the right to receive ordinary shares of PubCo, par value $0.0001 per share (the “Share Swap” and collectively with the SPAC Merger the “Business Combination”). On October 20, 2026, the sole shareholder of PubCo changed the name of PubCo from “CubeBio Holdings Limited” to “VIANIQ Holdings Limited”.

 

On November 11, 2026, at 11:00 a.m. Eastern Time, the Company held a special meeting of shareholders (the “Special Meeting”), at which the shareholders voted on the following proposals, as set forth below, each of which is described in detail in the definitive proxy statement (the “Proxy Statement”) filed with the U.S. Securities and Exchange Commission (the “SEC”) on October 20, 2026, which was first mailed by the Company to its shareholders on or about October 21, 2026.

 

As of September 14, 2026, the record date for the Special Meeting, there were 2,873,023 shares of common stock of the Company, par value $0.0001 per share (the “Common Stock”), issued and outstanding and entitled to vote at the Special Meeting. There were 2,419,694 shares of Common Stock representing approximately 84.22% of the issued and outstanding shares of Common Stock present in person (virtually) or represented by proxy at the Special Meeting, constituting a quorum for the Special Meeting. The final voting results for each proposal submitted to the shareholders of the Company at the Special Meeting are included below.

 

Each of the proposals described below was approved by the Company’s shareholders.

 

PROPOSALS

 

1. Business Combination Agreement Proposal

 

Stockholders approved the proposal (the “Business Combination Agreement Proposal”) to approve the Business Combination Agreement and approve the Business Combination and other transactions contemplated in the Business Combination Agreement.

 

Approval of the Business Combination Agreement Proposal required the approval of an ordinary resolution, being the affirmative vote of the holders of a majority of the Common Stock who, being present in person (including virtually) or represented by proxy and entitled to vote at the Special Meeting, voted at the Special Meeting. Abstentions had the same effect as a vote “AGAINST” the Business Combination Agreement Proposal, and broker non-votes had no effect on the outcome of the vote. The Business Combination Agreement Proposal received the following votes: 

 

FOR   AGAINST   ABSTAIN   Broker Non-Votes
2,419,694   0   0   0

 

The Business Combination Agreement Proposal was approved by stockholders holding 84.22% of the votes cast.

 

1

 

 

2. Governance Proposal

 

Stockholders approved, on a non-binding advisory basis, the proposal to adopt PubCo’s Amended and Restated Memorandum and Articles of Association (the “Proposed PubCo Charter”) in substitution for and to the exclusion of the Mountain Crest Amended and Restated Certificate of Incorporation (the “Mountain Crest’s Charter”). The differences between Mountain Crest’s and the Proposed PubCo Charter include, among other things, (i) a change in the authorized shares of capital stock from 30,000,000 shares of Mountain Crest common stock to 990,000,000 PubCo ordinary shares and 10,000,000 PubCo preference shares and (ii) the deletion of certain provisions related to Mountain Crest’s status as a blank check company.

 

Approval of the advisory, non-binding Governance Proposal required the affirmative vote of the majority of the Common Stock present in person (including virtually) or represented by proxy at the Special Meeting and entitled to vote on such Proposal. The vote on the Governance Proposal is advisory and is not binding on the Company or its board of directors. The Governance Proposal received the following votes:

 

FOR   AGAINST   ABSTAIN   Broker Non-Votes
2,419,694   0   0   0

 

The Governance Proposal was approved by stockholders holding 84.22% of the votes cast.

 

3.Director Proposal

 

Stockholders approved, on a non-binding advisory basis, the election of (i) Jaemyung Kim, (ii) Hyejeoung Lee, (iii) Dr. Hoseong Han, (iv) Dr. Kyungha Yoo, (v) Kyoomyong Yun, (vi) Dongseop Shin, and (vii) Hong Kyu Jeon as directors of PubCo. Proposal 3 was referred to in the Proxy Statement as the “Director Proposal”.

 

For the Director Proposal, each nominee was required to receive a plurality of the votes of the Common Stock present in person (including virtually) or represented by proxy at the Special Meeting and entitled to vote on the Director Proposal. Broker non-votes had no effect on the outcome of the vote. Each nominee received the following votes:

 

NOMINEE   FOR   WITHHELD   BROKER NON-VOTES
Jaemyung Kim   2,419,694   0   0
Hyejeoung Lee   2,419,694   0   0
Dr. Hoseong Han   2,419,694   0   0
Dr. Kyungha Yoo   2,419,694   0   0
Kyoomyong Yun   2,419,694   0   0
Dongseop Shin   2,419,694   0   0
Hong Kyu Jeon   2,419,694   0   0

 

All of the individual director nominated in the Directors Proposal were elected to the Board of Directors of PubCo.

 

4.PubCo Equity Incentive Plan Proposal

 

Stockholders approved PubCo’s Equity Incentive Plan.

 

2

 

 

Approval of the PubCo Equity Incentive Plan Proposal required the affirmative vote of the holders of a majority of the shares of Common Stock present in person (including virtually) or represented by proxy at the Special Meeting and entitled to vote on such Proposal. Abstentions had the same effect as a vote “AGAINST” the PubCo Equity Incentive Plan Proposal, and broker non-votes had no effect on the outcome of the vote. The PubCo Equity Incentive Plan Proposal received the following votes:

 

FOR   AGAINST   ABSTAIN   Broker Non-Votes
2,419,694   0   0   0

 

The PubCo Equity Incentive Plan Proposal was approved by stockholders holding 84.22% of the votes cast.

 

5.Adjournment Proposal

 

Because there were sufficient votes at the time of the Special Meeting to approve each of the foregoing proposals, the proposal to adjourn the Special Meeting to a later date or dates (the “Adjournment Proposal”), as described in the Proxy Statement, was not presented to the Company’s stockholders.

 

Item 8.01. Other Events.

 

In connection with the stockholders’ vote at the Special Meeting on November 11, 2026, 5,612 shares of the Company’s publicly traded common stock were tendered for redemption.

 

No Offer or Solicitation

 

This Current Report on Form 8-K is for informational purposes only and is not intended to and shall not constitute a proxy statement or the solicitation of a proxy, consent or authorization with respect to any securities or in respect of an initial business combination or PIPE financing and is not intended to and shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy or subscribe for any securities or a solicitation of any vote of approval, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

 

Item 9.01. Financial Statements and Exhibits.

 

EXHIBIT NO.   DESCRIPTION
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 12, 2026  
   
MOUNTAIN CREST ACQUISITION CORP. V  
   
By: /s/ Suying Liu  
Name: Suying Liu  
Title: Chief Executive Officer  

 

4

Filing Exhibits & Attachments

4 documents

Keep reading